StockData
Wave Life Sciences, Inc. logo

Wave Life Sciences, Inc. (WVE) stock

WVENasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 10/3047% below fair value
$2.77−0.07 (-2.46%)

Close on Nov 18, 2026Market cap $546.32MP/E –Yield –

Wave Life Sciences price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Wave Life Sciences's price to book ratio was 1.5× on Nov 11, 2026, against 10.7× a year earlier. Over the last 5 years it ranged from 1.5× to 31.8×, with a median of 6.3×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.5×−20.4
2025Dec 31, 202521.9×+8.9
2024Dec 31, 202413.0×−0.5
2022Oct 31, 202213.4×+8.0
2021Dec 31, 20215.5×+1.9
2020Dec 31, 20203.5×+1.2
2019Dec 31, 20192.4×−9.2
2018Dec 31, 201811.6×+5.7
2017Dec 29, 20175.9×+1.8
2016Dec 30, 20164.1×–

More Wave Life Sciences figures

See a number that looks wrong?